Abbott to Adopt Cell Imaging Software for its Automated Vysis ALK FISH Probe Test
Automated scans of FISH test slides of lung cancer cells preserve results, and enhance objectivity.
Read More
Search Results for: lung cancer
JAMA Study Shows Efficacy of Life Technologies’ Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
Life Technologies Corp, Carlsbad, Calif, announced publication of a study that underscores the clinical utility of the company’s early stage lung cancer test.
Read MoreAbbott Introducing Vysis ALK Fish Probe Kit to EU
Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit, allowing the test to be marketed in the European Union as a companion diagnostic.
Read MoreIgenuity Systems to Partner with Life Technologies to Develop Solutions for Interpreting Clinical Dx Tests
Ingenuity Systems’ software and content will be provided to interpreting physicians, such as molecular pathologists and medical geneticists, in a dedicated portal for the interpretation of Life’s molecular diagnostic test kits.
Read MoreNeoGenomics Webinar: Lung, Colon Cancer Molecular Testing Strategies
Barbara Chaitin, MD, will present the most updated practice guidelines in oncology from the National Cancer Center Network and discuss the pathologist’s role in molecular testing strategies, including EGFR, KRAS, and ALK testing in NSCLC, KRAS/BRAF testing in colorectal cancer, and screening for Lynch Syndrome in colon cancer specimens.
Read More